Selected Grants
Developing A Novel Combinatorial Therapy for Lethal Neuroendocrine Prostate Cancer
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2022 - 2027Targeting Ferroptosis in Lethal RB1 Deficient Prostate Cancer
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2022 - 2027Engineering Large Chromosomal Deletions in Mice to Advance Precision Oncology for Prostate Cancer
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2022 - 2027Targeting NUAK2 in neuroendocrine prostate cancer
ResearchCo Investigator · Awarded by Department of Defense · 2023 - 2026Cell and Molecular Biology Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026Targeting NUAK2 to mitigate obesity-enhanced prostate cancer growth and metastasis
ResearchCo Investigator · Awarded by Department of Defense · 2021 - 2024Exploiting Ferroptosis for the Treatment of RB1-Deficient Lethal Prostate Cancer
ResearchMentor · Awarded by Department of Defense · 2022 - 2024Heat Shock Factor 1 drives prostate cancer progression through production of antioxidants and cellular energy
ResearchMentor · Awarded by Department of Defense · 2021 - 2023De Novo Lipogenesis and Chemosensitivity of Prostate Cancer
ResearchPrincipal Investigator · Awarded by Department of Defense · 2020 - 2023Exploiting ferroptosis for the treatment of lethal neuroendocrine prostate cancer
ResearchPrincipal Investigator · Awarded by Mike Slive Foundation · 2021 - 2021Fellowships, Gifts, and Supported Research
Leukemia & Lymphoma Society Special Fellow Award (declined) ·
2012
- 2015
Awarded by: Leukemia & Lymphoma Society
Department of Defense Prostate Cancer Research Program Postdoctoral Fellowship Award ·
2012
- 2014
Awarded by: the Department of Defense (DoD)
Lung Cancer Research Foundation (LCRF) Grant Award ·
2011
- 2012
Awarded by: Lung Cancer Research Foundation
External Relationships
- Chinese Urological Associate
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.